There are many powerful catalysts in the market: Tandem Diabetes Care Inc. (TNDM) can be one of them

Tandem Diabetes Care Inc. (NASDAQ: TNDM) closed the day trading at $41.74 down -2.25% from the previous closing price of $42.70. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 663430 shares were traded. TNDM stock price reached its highest trading level at $43.12 during the session, while it also had its lowest trading level at $41.54.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

For a better understanding of TNDM, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 85.95. For the most recent quarter (mrq), Quick Ratio is recorded 4.20 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.

Upgrades & Downgrades

On October 18, 2022, Barclays started tracking the stock assigning a Overweight rating and target price of $75.

On October 12, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $75.Jefferies initiated its Buy rating on October 12, 2022, with a $75 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 when BERGER DAVID B sold 10,000 shares for $40.25 per share. The transaction valued at 402,500 led to the insider holds 3,029 shares of the business.

BERGER DAVID B sold 15,000 shares of TNDM for $604,800 on Dec 15. The EVP & Chief Operating Officer now owns 3,029 shares after completing the transaction at $40.32 per share. On Jun 08, another insider, BERGER DAVID B, who serves as the EVP & Chief Operating Officer of the company, sold 10,097 shares for $65.02 each. As a result, the insider received 656,515 and left with 2,457 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.27 while its Price-to-Book (P/B) ratio in mrq is 6.35.

Stock Price History:

Over the past 52 weeks, TNDM has reached a high of $125.54, while it has fallen to a 52-week low of $33.51. The 50-Day Moving Average of the stock is 41.63, while the 200-Day Moving Average is calculated to be 58.87.

Shares Statistics:

Over the past 3-months, TNDM traded about 1.20M shares per day on average, while over the past 10 days, TNDM traded about 1.23M shares per day. A total of 64.24M shares are outstanding, with a floating share count of 62.97M. Shares short for TNDM as of Oct 13, 2022 were 5.59M with a Short Ratio of 5.32M, compared to 4.52M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.70% and a Short% of Float of 9.73%.

Earnings Estimates

Current recommendations for the stock of the company come from 13 analysts. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of $0.06 and a low estimate of -$0.18, while EPS last year was $0.09. The consensus estimate for the next quarter is $0.24, with high estimates of $0.4 and low estimates of $0.1.

Analysts are recommending an EPS of between -$0.13 and -$0.45 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is $0.39, with 13 analysts recommending between $0.91 and -$0.01.

Revenue Estimates

A total of 14 analysts have provided revenue estimates for TNDM’s current fiscal year. The highest revenue estimate was $847.4M, while the lowest revenue estimate was $819.83M, resulting in an average revenue estimate of $836.4M. In the same quarter a year ago, actual revenue was $702.8M, up 19.00% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $981.18M in the next fiscal year. The high estimate is $1.03B and the low estimate is $925.7M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.